UTAH’S LIFE SCIENCES INDUSTRY TAKES TO THE HILL
January 30, 2023
Utah’s vibrant life sciences industry was on full display January 27 as part of the Governor’s Office of Economic Opportunity “Life Sciences Day on the Hill”. The event, held at the state capitol, provided lawmakers the opportunity to interact one-on-one with leaders from local med tech, biotech and diagnostics companies. More than two dozen companies exhibited their life-changing innovations and helped legislators understand first hand the tests, technologies and treatments they’re developing to fight cancer, degenerative back pain, heart disease, neurological disorders, Parkinson’s, stroke and more.
The state’s life sciences industry accounts for over 130,000 jobs at above average wages and contributes more than $13 billion in GDP.
“These companies are just a sampling of our industry’s commitment to innovation and advancing healthcare to improve and save countless lives,” said Kelvyn Cullimore, president and CEO of BioUtah.
Companies that participated included:
- Altitude Lab
- ARUP Laboratories
- ATL Technology
- BD
- Biolexis Therapeutics
- Blackrock Neurotech
- Canyon Labs
- Co-Diagnostics, Inc.
- Echelon Biosciences
- Edwards Lifesciences
- Espiritu
- Illumina
- Imessa Research
- Inherent Biosciences
- IONIQ Sciences
- Known Medicine
- Kolosis BIO
- PhotoPharmics
- Piper Access
- PIVOT Center University of Utah
- Quansys Biosciences
- Spectrum Solutions
- Stryker
- University of Utah Health
Recent News
- Biolexis Therapeutics Advances Breakthrough GLP-1 and AMPK Programs into First-in-Human Clinical Trials
- Rebel Medicine Announces Series A Financing and Investigational New Drug (IND) Application Opening to Advance Non‑Opioid Pain Therapeutic into Clinical Development
- NUSANO STABLE ISOTOPE PROGRAM ENRICHES GADOLINIUM-160 TO 99.2% PURITY
- CancerVax Targets Liver Cancers to Further Showcase Flexibility of Its Universal Platform
- Seek Labs Unveils BioSeeker™
- Halia Therapeutics Completes Enrollment in Phase 2a Clinical Trial of HT-6184 for Myelodysplastic Syndrome (MDS)